63-Year-Old Female Experiences Slow Relapse
Evelyn, now 63, was diagnosed with multiple myeloma when she was 58. She is a district manager for her company and has an erratic travel schedule. She is a current smoker.
She was considered standard risk. She had Vd induction followed by an autologous stem cell transplantation.
About three years...
-
Mark Fesler5yrElo or dara or kyprolis + rev or Pom + dex This is a situation I like elo to save bigger guns for a symptomatic relapse Could be Show More
-
Sherif Badawy5yrGiven what we know about safety and efficacy data as well as potential benefits for quality of life outcomes, adding Daratumumab and Dex would have potential clinical benefits as best Show More
Show More Comments
Proteomics-Based Approach Reveals the Involvement of SERPINB9 in Recurrent and Relapsed Multiple Myeloma
Source : https://pubs.acs.org/doi/abs/10.1021/acs.jproteome.1c00007
Multiple myeloma (MM) is a common hematological malignancy with poorly understood recurrence and relapse mechanisms. Notably, bortezomib resistance leading to relapse makes MM treatment significantly challenging. To clarify the drug...
Latest Developments in Cellular Therapy for Multiple Myeloma - touchONCOLOGY
Source : https://doi.org/10.17925/OHR.2021.16.2.111
Multiple myeloma (MM) is a malignant clonal disorder of plasma cells in the bone marrow, and more than 32,000 new cases are expected in the USA each year.1 Many clinical...
Promising Anti-Mitochondrial Agents for Overcoming Acquired Drug Resistance in Multiple Myeloma
Source : https://www.mdpi.com/2073-4409/10/2/439
Multiple myeloma (MM) remains an incurable tumor due to the high rate of relapse that still occurs. Acquired drug resistance represents the most challenging obstacle to the extension of survival...